3-hydroxyephedrine has been researched along with Diabetic Angiopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirkwood, I; Larkin, D; Marinescu, V; Pop-Busui, R; Raffel, DM; Schmid, H; Schroeder, J; Stevens, MJ; Yamada, E | 1 |
1 other study(ies) available for 3-hydroxyephedrine and Diabetic Angiopathies
Article | Year |
---|---|
Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
Topics: Adenosine; Adult; Autonomic Nervous System Diseases; C-Reactive Protein; Carbon Radioisotopes; Contrast Media; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diastole; Ephedrine; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxidative Stress; Vasoconstriction; Ventricular Dysfunction, Left; von Willebrand Factor | 2004 |